RNASEH2A
Ribonuclease H2 subunit A
Also known as: AGS4, RNASEHI, RNH2A_HUMAN, RNHIA, RNHL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75792
- Gene
- RNASEH2A
- Ensembl
- ENSG00000104889
- Chromosome
- 19
- Canonical length
- 299 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.[provided by RefSeq, Aug 2009]
Canonical amino-acid sequenceUniProt
299 residues, UniProt reviewed canonical sequence.
>O75792|RNASEH2A
1 MDLSELERDN TGRCRLSSPV PAVCRKEPCV LGVDEAGRGP VLGPMVYAIC YCPLPRLADL
61 EALKVADSKT LLESERERLF AKMEDTDFVG WALDVLSPNL ISTSMLGRVK YNLNSLSHDT
121 ATGLIQYALD QGVNVTQVFV DTVGMPETYQ ARLQQSFPGI EVTVKAKADA LYPVVSAASI
181 CAKVARDQAV KKWQFVEKLQ DLDTDYGSGY PNDPKTKAWL KEHVEPVFGF PQFVRFSWRT
241 AQTILEKEAE DVIWEDSASE NQEGLRKITS YFLNEGSQAR PRSSHRYFLE RGLESATSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNASEH2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 26 nTPM
- thymus: 23 nTPM
- tonsil: 18 nTPM
- esophagus: 17 nTPM
- lymph node: 16 nTPM
- testis: 14 nTPM
Single-cell type
- enteric transient amplifying cells: 17 nCPM
- megakaryocytes: 12 nCPM
- extravillous trophoblasts: 12 nCPM
- paneth cells: 12 nCPM
- migrating cytotrophoblasts: 9.3 nCPM
- enteric stem cells: 8.7 nCPM
Immune cell
- NK-cell: 45 nTPM
- memory B-cell: 37 nTPM
- naive B-cell: 36 nTPM
- non-classical monocyte: 28 nTPM
- intermediate monocyte: 28 nTPM
- T-reg: 26 nTPM
Brain region
- white matter: 18 nTPM
- cerebellum: 18 nTPM
- medulla oblongata: 15 nTPM
- pons: 14 nTPM
- basal ganglia: 14 nTPM
- cerebral cortex: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RNASEH2A.
Disease | AllUniProt
Conditions RNASEH2A is implicated in, by any mechanism.
- Aicardi-Goutieres syndrome 4 (AGS4) MIM:610333
Disease | GeneticClinVar
44 pathogenic / likely-pathogenic of 563 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Aicardi-Goutieres syndrome 4
- Aicardi Goutieres syndrome
- RNASEH2A-related disorder
- Inborn genetic diseases
- RNASEH2A-related type 1 interferonopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribonuclease H-like superfamily
- Ribonuclease H superfamily
- Ribonuclease HII/HIII
- Ribonuclease H2, subunit A
- Ribonuclease HII, helix-loop-helix cap domain superfamily
- Ribonuclease HII/HIII domain
- Ribonuclease HII
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNASEH2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNASEH2A as an antibody target. Whether an autoantibody or antibody against RNASEH2A could matter depends on whether native RNASEH2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNASEH2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNASEH2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...